Goldman Sachs Group Inc

Goldman Sachs Group Inc is a declared insider at 24 companies; the most frequent names are Attovia Therapeutics, Inc., Flywire Corp and Sweetgreen, Inc. Between 5 January 2016 and 6 August 2026, the trades on record add up to 191 filings.

On the open market, the record shows 53 purchases worth €20.9M and 103 sales worth €857.3M. The totals exclude 8 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 42 purchases and 56 sales.

The median purchase comes to €1,660. Measured against the company's value, the median purchase equals 0.0002% of market capitalisation, across 11 purchases where it is known. On 5 out of 44 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 36 purchases show a median change of +31.0%, with the price up in 83% of them. These figures describe past trades and do not predict future prices.

The newest entry dates from 28 August 2026: an open-market sale of €13k, in Attovia Therapeutics, Inc. The last insider purchase was made public on 28 August 2026, 51 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.